Skip to main content

Clinical Research from Clinical Investigation Services

Call Today to Qualify

Open Hours

Monday – Friday 8 am to 5pm

Are you at risk of developing health complications due to obesity?

Obesity is a chronic health condition with a complex set of contributing factors, and losing weight can be difficult.

According to the Center for Disease Control (CDC), between 35-40% of adults in Wisconsin have obesity: "Adults with obesity are at increased risk for many other serious health conditions, including heart disease, stroke, type 2 diabetes, some cancers, severe outcomes from COVID-19, and poor mental health. Additionally, people with obesity report being stigmatized because of their weight."

The SYNCHRONIZE-CVOT Trial by Boehringer Ingelheim is testing if the study drug may help lower blood sugar levels, prevent obesity-related conditions such as Type 2 Diabetes, and improve quality of life.

Dr. Bharati Pulla is the leading physician ("principal investigator") for this trial at our clinic in Kenosha, WI. We are currently accepting new patients for this study.

For more information on this clinical trial, please fill out the contact form below or call us at 262-925-1280 and ask to speak to our recruiters.



"Adult Obesity Prevalence Remains High; Support for Prevention and Treatment Needed". Press Release. Thursday, September 21, 2023. Center for Disease Control (CDC).


Study Protocol: BI 1404-0040

General Contact Form
Select the best time(s) to contact you.

Dr. Eva Agaiby

President, Director of Clinical Trials & Regulatory Affairs

View Profile

Allen Banoub, MBA

Director of Marketing & Business Development

View Profile